SM04690, a Potential Disease-Modifying Treatment for Knee Osteoarthritis, Functions Through Inhibition of CLK2 and DYRK1A, Novel Molecular Regulators of WNT Signaling, Chondrogenesis, and Inflammation

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.053